Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q59167413 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241120235921.0 | ||
008 | 241120nneanz||abbn n and d | ||
035 | ‡a (WKP)Q59167413 | ||
024 | ‡a 0000-0002-4419-5124 ‡2 orcid | ||
024 | ‡a 15020823400 ‡2 scopus | ||
035 | ‡a (OCoLC)Q59167413 | ||
100 | 0 | ‡a Francisco J Martínez-Lobo ‡9 it ‡9 es ‡9 ast | |
375 | ‡a 1 ‡2 iso5218 | ||
400 | 0 | ‡a Francisco J Martínez-Lobo ‡c researcher ORCID ID = 0000-0002-4419-5124 ‡9 en | |
400 | 0 | ‡a Francisco J Martínez-Lobo ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's Antibacterial activity and mode of action of a commercial citrus fruit extract. | ||
670 | ‡a Author's C-reactive protein, haptoglobin and Pig-Major acute phase protein profiles of pigs infected experimentally by different isolates of porcine reproductive and respiratory syndrome virus. | ||
670 | ‡a Author's Comparative pathogenicity of type 1 and type 2 isolates of porcine reproductive and respiratory syndrome virus | ||
670 | ‡a Author's Comparative pathogenicity of type 1 and type 2 isolates of porcine reproductive and respiratory syndrome virus (PRRSV) in a young pig infection model. | ||
670 | ‡a Author's Cross-reactions in specific Brachyspira spp. PCR assays caused by "Brachyspira hampsonii" isolates: implications for detection. | ||
670 | ‡a Author's Detection of Teschovirus type 13 from two swine herds exhibiting nervous clinical signs in growing pigs. | ||
670 | ‡a Author's Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts | ||
670 | ‡a Author's Evaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriae | ||
670 | ‡a Author's Experimental infection of conventional pigs with a 'Brachyspira hampsonii' isolate recovered from a migrating waterfowl in Spain | ||
670 | ‡a Author's First identification of "Brachyspira hampsonii" in wild European waterfowl | ||
670 | ‡a Author's GP3 is a structural component of the PRRSV type II | ||
670 | ‡a Author's GP3 is a structural component of the PRRSV type II (US) virion. | ||
670 | ‡a Author's Immunisation of pigs with a major envelope protein sub-unit vaccine against porcine reproductive and respiratory syndrome virus | ||
670 | ‡a Author's Immunisation of pigs with a major envelope protein sub-unit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV) results in enhanced clinical disease following experimental challenge. | ||
670 | ‡a Author's Porcine Reproductive and Respiratory Syndrome Virus isolates differ in their susceptibility to neutralization. | ||
670 | ‡a Author's Safety of Porcine Reproductive and Respiratory Syndrome Modified Live Virus | ||
670 | ‡a Author's Safety of Porcine Reproductive and Respiratory Syndrome Modified Live Virus (MLV) vaccine strains in a young pig infection model | ||
670 | ‡a Author's Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred. | ||
670 | ‡a Author's Swine dysentery: aetiology, pathogenicity, determinants of transmission and the fight against the disease. | ||
909 | ‡a (scopus) 15020823400 ‡9 1 | ||
909 | ‡a (orcid) 0000000244195124 ‡9 1 | ||
919 | ‡a 1identificationofbrachyspirahampsoniiinwildeuropeanwaterfowl ‡A First identification of "Brachyspira hampsonii" in wild European waterfowl ‡9 1 | ||
919 | ‡a experimentalinfectionofconventionalpigswithabrachyspirahampsoniiisolaterecoveredfromamigratingwaterfowlinspain ‡A Experimental infection of conventional pigs with a 'Brachyspira hampsonii' isolate recovered from a migrating waterfowl in Spain ‡9 1 | ||
919 | ‡a evaluationoftheinvitroactivityofflumequineagainstfieldisolatesofbrachyspirahyodysenteriae ‡A Evaluation of the in vitro activity of flumequine against field isolates of Brachyspira hyodysenteriae ‡9 1 | ||
919 | ‡a effectsof2commercialeuropeanmodifiedlivevaccinesagainstporcinereproductiveandrespiratorysyndromevirusesinpregnantgilts ‡A Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts ‡9 1 | ||
919 | ‡a detectionofteschovirustype13from2swineherdsexhibitingnervousclinicalsignsingrowingpigs ‡A Detection of Teschovirus type 13 from two swine herds exhibiting nervous clinical signs in growing pigs. ‡9 1 | ||
919 | ‡a crossreactionsinspecificbrachyspiraspppcrassayscausedbybrachyspirahampsoniiisolatesimplicationsfordetection ‡A Cross-reactions in specific Brachyspira spp. PCR assays caused by "Brachyspira hampsonii" isolates: implications for detection. ‡9 1 | ||
919 | ‡a comparativepathogenicityoftype1andtype2isolatesofporcinereproductiveandrespiratorysyndromevirusprrsvinayoungpiginfectionmodel ‡A Comparative pathogenicity of type 1 and type 2 isolates of porcine reproductive and respiratory syndrome virus (PRRSV) in a young pig infection model. ‡9 1 | ||
919 | ‡a comparativepathogenicityoftype1andtype2isolatesofporcinereproductiveandrespiratorysyndromevirus ‡A Comparative pathogenicity of type 1 and type 2 isolates of porcine reproductive and respiratory syndrome virus ‡9 1 | ||
919 | ‡a 100reactiveproteinhaptoglobinandpigmajoracutephaseproteinprofilesofpigsinfectedexperimentallybydifferentisolatesofporcinereproductiveandrespiratorysyndromevirus ‡A C-reactive protein, haptoglobin and Pig-Major acute phase protein profiles of pigs infected experimentally by different isolates of porcine reproductive and respiratory syndrome virus. ‡9 1 | ||
919 | ‡a antibacterialactivityandmodeofactionofacommercialcitrusfruitextract ‡A Antibacterial activity and mode of action of a commercial citrus fruit extract. ‡9 1 | ||
919 | ‡a gp3isastructuralcomponentoftheprrsvtype2usvirion ‡A GP3 is a structural component of the PRRSV type II (US) virion. ‡9 1 | ||
919 | ‡a gp3isastructuralcomponentoftheprrsvtype2 ‡A GP3 is a structural component of the PRRSV type II ‡9 1 | ||
919 | ‡a swinedysenteryaetiologypathogenicitydeterminantsoftransmissionandthefightagainstthedisease ‡A Swine dysentery: aetiology, pathogenicity, determinants of transmission and the fight against the disease. ‡9 1 | ||
919 | ‡a similarityofeuropeanporcinereproductiveandrespiratorysyndromevirusstrainstovaccinestrainisnotnecessarilypredictiveofthedegreeofprotectiveimmunityconferred ‡A Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred. ‡9 1 | ||
919 | ‡a safetyofporcinereproductiveandrespiratorysyndromemodifiedlivevirus1055vaccinestrainsinayoungpiginfectionmodel ‡A Safety of Porcine Reproductive and Respiratory Syndrome Modified Live Virus (MLV) vaccine strains in a young pig infection model ‡9 1 | ||
919 | ‡a safetyofporcinereproductiveandrespiratorysyndromemodifiedlivevirus ‡A Safety of Porcine Reproductive and Respiratory Syndrome Modified Live Virus ‡9 1 | ||
919 | ‡a porcinereproductiveandrespiratorysyndromevirusisolatesdifferintheirsusceptibilitytoneutralization ‡A Porcine Reproductive and Respiratory Syndrome Virus isolates differ in their susceptibility to neutralization. ‡9 1 | ||
919 | ‡a immunisationofpigswithamajorenvelopeproteinsubunitvaccineagainstporcinereproductiveandrespiratorysyndromevirusprrsvresultsinenhancedclinicaldiseasefollowingexperimentalchallenge ‡A Immunisation of pigs with a major envelope protein sub-unit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV) results in enhanced clinical disease following experimental challenge. ‡9 1 | ||
919 | ‡a immunisationofpigswithamajorenvelopeproteinsubunitvaccineagainstporcinereproductiveandrespiratorysyndromevirus ‡A Immunisation of pigs with a major envelope protein sub-unit vaccine against porcine reproductive and respiratory syndrome virus ‡9 1 | ||
946 | ‡a b ‡9 1 | ||
996 | ‡2 LC|no 98031115 | ||
996 | ‡2 PTBNP|88063 | ||
996 | ‡2 J9U|987007518718805171 | ||
996 | ‡2 NUKAT|n 2019154902 | ||
996 | ‡2 J9U|987007438446205171 | ||
996 | ‡2 ISNI|0000000069223107 | ||
996 | ‡2 SUDOC|183695887 | ||
996 | ‡2 PTBNP|243771 | ||
996 | ‡2 ISNI|000000006859685X | ||
996 | ‡2 BNCHL|10000000000000000126541 | ||
996 | ‡2 ISNI|0000000069022807 | ||
996 | ‡2 BNE|XX4617209 | ||
996 | ‡2 ISNI|0000000083273901 | ||
996 | ‡2 PTBNP|1861139 | ||
996 | ‡2 BNE|XX948496 | ||
996 | ‡2 LC|nb2017012472 | ||
996 | ‡2 ISNI|000000005269501X | ||
996 | ‡2 DNB|131701657 | ||
996 | ‡2 DNB|1057575046 | ||
996 | ‡2 BNE|XX1106035 | ||
996 | ‡2 RERO|A016399296 | ||
996 | ‡2 LC|no2023083844 | ||
996 | ‡2 BNE|XX4767359 | ||
996 | ‡2 DNB|105324682X | ||
996 | ‡2 ISNI|0000000067763791 | ||
996 | ‡2 BLBNB|000327862 | ||
996 | ‡2 BNC|981058611838206706 | ||
996 | ‡2 BNF|17957828 | ||
996 | ‡2 LC|nr2001025650 | ||
996 | ‡2 ISNI|0000000383574474 | ||
996 | ‡2 DNB|1304450600 | ||
996 | ‡2 PTBNP|109816 | ||
996 | ‡2 ISNI|0000000049250730 | ||
996 | ‡2 DNB|118790889 | ||
996 | ‡2 PTBNP|346877 | ||
996 | ‡2 LC|no2004003483 | ||
996 | ‡2 SUDOC|174634897 | ||
996 | ‡2 ISNI|000000007052699X | ||
996 | ‡2 SUDOC|19078539X | ||
996 | ‡2 PTBNP|1625125 | ||
996 | ‡2 NTA|068948247 | ||
996 | ‡2 ISNI|0000000039003728 | ||
996 | ‡2 DNB|1208856154 | ||
996 | ‡2 NUKAT|n 2005106310 | ||
996 | ‡2 PTBNP|959617 | ||
996 | ‡2 ISNI|0000000079850884 | ||
996 | ‡2 DNB|1261583493 | ||
996 | ‡2 BNF|14040358 | ||
996 | ‡2 SUDOC|235256587 | ||
996 | ‡2 LC|no2016026435 | ||
996 | ‡2 PTBNP|237615 | ||
996 | ‡2 SUDOC|261585355 | ||
996 | ‡2 PLWABN|9812830031905606 | ||
996 | ‡2 PTBNP|1266365 | ||
996 | ‡2 BNE|XX6090790 | ||
996 | ‡2 NTA|227437861 | ||
996 | ‡2 CAOONL|ncf11744840 | ||
996 | ‡2 ISNI|0000000060492335 | ||
996 | ‡2 SUDOC|100511988 | ||
996 | ‡2 LC|n 99026445 | ||
996 | ‡2 BNF|17962388 | ||
996 | ‡2 BLBNB|000276375 | ||
996 | ‡2 LC|n 85055298 | ||
996 | ‡2 ISNI|000000050775817X | ||
996 | ‡2 ISNI|0000000068411720 | ||
996 | ‡2 SUDOC|075961121 | ||
996 | ‡2 LC|no2003003670 | ||
996 | ‡2 PTBNP|1783594 | ||
996 | ‡2 PTBNP|1438451 | ||
996 | ‡2 SZ|1261583493 | ||
996 | ‡2 ISNI|0000000116779950 | ||
996 | ‡2 NTA|086321897 | ||
996 | ‡2 PTBNP|170979 | ||
996 | ‡2 SUDOC|029476488 | ||
996 | ‡2 ISNI|0000000458031619 | ||
996 | ‡2 BNE|XX1059119 | ||
996 | ‡2 DNB|1089157487 | ||
996 | ‡2 BNC|981058517165106706 | ||
996 | ‡2 SUDOC|16935735X | ||
996 | ‡2 SUDOC|203819977 | ||
996 | ‡2 LNB|LNC10-000259753 | ||
996 | ‡2 LC|n 88186565 | ||
996 | ‡2 DNB|111933246X | ||
996 | ‡2 NUKAT|n 2023165505 | ||
996 | ‡2 PTBNP|121899 | ||
996 | ‡2 BNE|XX1178884 | ||
996 | ‡2 PTBNP|35858 | ||
996 | ‡2 BAV|495_212518 | ||
996 | ‡2 BAV|495_248674 | ||
996 | ‡2 PTBNP|1888525 | ||
996 | ‡2 RERO|A027332889 | ||
996 | ‡2 ISNI|0000000069084346 | ||
996 | ‡2 DNB|1157343880 | ||
996 | ‡2 BNE|XX6303880 | ||
996 | ‡2 DNB|1056181877 | ||
996 | ‡2 LC|no2007006819 | ||
996 | ‡2 LC|nb2015002451 | ||
996 | ‡2 BIBSYS|90661230 | ||
996 | ‡2 ISNI|0000000066323911 | ||
996 | ‡2 NKC|xx0234305 | ||
996 | ‡2 BAV|495_35017 | ||
996 | ‡2 BAV|495_35016 | ||
996 | ‡2 ISNI|0000000068790513 | ||
996 | ‡2 PTBNP|145932 | ||
996 | ‡2 PLWABN|9814026877005606 | ||
996 | ‡2 ISNI|0000000070317303 | ||
996 | ‡2 SUDOC|117782580 | ||
996 | ‡2 BIBSYS|2036283 | ||
996 | ‡2 BLBNB|001375818 | ||
996 | ‡2 J9U|987007383906505171 | ||
996 | ‡2 DNB|1056543396 | ||
996 | ‡2 RERO|A005491359 | ||
996 | ‡2 LC|no2008148707 | ||
996 | ‡2 ISNI|0000000066325677 | ||
996 | ‡2 PTBNP|85365 | ||
996 | ‡2 NKC|jo2016915657 | ||
996 | ‡2 LC|n 88651039 | ||
996 | ‡2 PTBNP|1158470 | ||
996 | ‡2 SUDOC|084744693 | ||
996 | ‡2 NTA|375545034 | ||
996 | ‡2 NTA|075259052 | ||
996 | ‡2 LC|no 00027622 | ||
996 | ‡2 ISNI|0000000060384473 | ||
996 | ‡2 LC|nb 99153699 | ||
996 | ‡2 BNF|12109563 | ||
996 | ‡2 LC|no 98120464 | ||
996 | ‡2 LC|no2007140810 | ||
996 | ‡2 J9U|987007352849205171 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |